TTrialPathMatch Me to Trials
← Back to trials
RecruitingMild Cognitive Impairment

Closed-Loop Brain Stimulation as a Potential Intervention for Cognitive Decline

Eligible age

18–90 yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The goal of this clinical study is to investigate the effectiveness of non-invasive stimulation to enhance cognitive control abilities in cognitively healthy adults and older adults diagnosed with mild cognitive disorder (MCI). The main questions it aims to answer are: * whether it is possible to restore various cognitive functions in older adults diagnosed with MCI by delivering theta burst stimulation (TBS), a form of transcranial magnetic stimulation, and * whether closed-loop TBS is able to induce therapeutic benefits that outperform open-loop TBS. Participants play a cognitive video game while a brain-computer interface (BCI) analyzes their electroencephalogram (EEG) signals and decodes the presence or absence of the contingent negative variation (CNV) potential, a marker of cognitive control. The BCI triggers TBS when its outputs indicate that the participant is not engaged properly in the video game. Researchers will compare the effects of sham, closed-loop, and open-loop TBS using the outcome metrics described below to see how much cognitive restorations is achievable with each stimulation modality.

Sponsor: University of Texas at Austin

You may qualify if…

  • Cognitively normal younger adults
  • 1. Ages between 18 to 35 years
  • 2. Good general health
  • 3. Normal or corrected vision
  • 4. Completed elementary school education or able to understand middle school level experiment instructions
  • Cognitively normal older adults
  • 1. Ages between 60 to 90 years
  • 2. Good general health

You may not qualify if…

  • 1. Neurological or psychiatric diseases (e.g., personal history of epilepsy/seizure brain damage, multiple sclerosis, schizophrenia, substance use disorder, etc.).
  • 2. Current use of psychotropic medications with cognitive side effects (e.g., benzodiazepines, anticonvulsants, antipsychotics, etc.)
  • 3. Current use of cognitive enhancing medications (e.g., Adderall, Memantine, etc.)
  • 4. Factors hindering EEG acquisition and TMS delivery (e.g., skin infection, wounds, dermatitis, etc.)
  • 5. Factors hindering MRI acquisition (e.g., implants, metallic tattoos, etc.)

Where it's recruiting

Texas

Austin

Source: ClinicalTrials.gov · NCT05907343 · last updated 2026-04-29